Netherlands (NL)

Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic Cardiomyopathy (2021) De Marvao A, Mcgurk KA, Zheng SL, Thanaj M, Bai W, Duan J, Biffi C, et al. Journal article An automated approach for developing neural network interatomic potentials with FLAME (2021) Mirhosseini H, Tahmasbi H, Kuchana SR, Ghasemi SA, Kühne TD Journal article PET- And SPECT-based navigation strategies to advance procedural accuracy in interventional radiology and image-guided surgery (2021) Boekestijn I, Azargoshasb S, Schilling C, Navab N, Rietbergen D, Van Oosterom MN Journal article, Review article The burden of traumatic brain injury from low-energy falls among patients from 18 countries in the CENTER-TBI Registry: A comparative cohort study (2021) Lecky FE, Otesile O, Marincowitz C, Majdan M, Nieboer D, Lingsma HF, Maegele M, et al. Journal article An ongoing, randomized phase II study of Nivolumab plus Ipilimumab versus standard of care in previously untreated and advanced non-clear cell renal cell carcinoma (SUNIFORECAST) (2021) Ahrens M, Escudier B, Haanen JBAG, Boleti E, Goupil GM, Grimm MO, Negrier S, et al. Conference contribution Clusters of Psoriatic Arthritis Patients at Baseline Based on Different Ultrasound Detected Synovitis: Exploratory Analysis from a Phase III Study (2021) D'Agostino MA, Schett G, Gaillez C, Conaghan P, Naredo E, Carron P, Burgos-Vargas R, et al. Conference contribution Ultrasound Demonstrates Continued Improvement in Psoriatic Arthritis Synovitis and Enthesitis with Secukinumab: 52-week Results from a Phase III Study (2021) D'Agostino MA, Schett G, Gaillez C, Guerrero C, Hanova P, Cazenave T, Stoenoiu MS, et al. Conference contribution Humoral Immune Responses to SARS-CoV2 Infections and upon Vaccination Against SARS-CoV2 (2021) Finzel S, Peter N, Brand C, Fischer B, Keller B, Weigang S, Kochs G, et al. Conference contribution Sharing awe: Vicarious transcendent experiences via social media (2021) Possler D, Meier A, Boerner S, Gilbert A, Scherer H Conference contribution, Abstract of a poster The Phase 3 NETTER-1 Study of [Lu-177]Lu-DOTA-TATE in Patients with Midgut Neuroendocrine Tumours: Final Overall Survival and Long-Term Renal Safety (2021) Kunz P, Caplin ME, Ruszniewski PB, Bodei L, Hendifar A, Mittra E, Wolin EM, et al. Conference contribution